FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

E-ISSN： 1873-5576|8|5|342-348

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.5, 2008-08, pp. : 342-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients

By Rossi Antonio Maione Paolo Gridelli Cesare

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 1051-1067

Informa Healthcare

Access to resources Recommend Favorite

Role of Genotyping in Non-Small Cell Lung Cancer Treatment: Current Status

By Bonanno Laura Favaretto Adolfo Rugge Massimo Taron Miquel Rosell Rafael

Drugs, Vol. 71, Iss. 17, 2011-12 ,pp. : 2231-2246

Adis International

Access to resources Recommend Favorite

Taxanes for advanced non-small cell lung cancer

By Ramalingam Sakkaraiappan Belani Chandra P

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1693-1709

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed in advanced non-small cell lung cancer

By Gridelli Cesare Maione Paolo Rossi Antonio Bareschino Maria Anna Schettino Clorinda Sacco Paola Claudia Zeppa Rosario

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combination

By Esteban-Gonzalez Emilio Fernández Yolanda Villanueva Noemí Fra Joaquin Muñiz Isabel Palacio Isabel Vieitez Jose Uña Esther Mareque Beatriz Lacave Angel

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 597-601

Springer Publishing Company

Access to resources Recommend Favorite